August 2025: Teva Pharmaceuticals launched the first FDA-approved generic of Saxenda (liraglutide injection) in the United States, expanding lower-cost options for prescribers
The net result is reduced caloricintake and improved blood sugar regulation
Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis
Sequence Flip Many consumers will quietly flip the sequence from: Diet + exercise if I fail, Ill take a drug to Ill start GLP-1 then maybe Ill sort out diet + exercise. This is human nature: if a powerful tool exists, people want it early , not as a last resort
Exploring other medication options due to Wegovy sulfur burps For those affected by sulfur burps, exploring other weight loss medications might be helpful
Affordable tirzepatide options through compounding pharmacies have been one of the driving forces behind the popularity of compound formulations